Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell Carcinoma

Clinical trial NCT04716751 · UNKNOWN

Trial details

NCT number: NCT04716751
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Tracheal Squamous Cell Carcinoma

Start date: 2021-02-01
Primary completion: 2022-01-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.